<DOC>
	<DOCNO>NCT01885780</DOCNO>
	<brief_summary>This clinical phase IV study open , prospective phase IV study act evaluate effectiveness femtolaser-assisted astigmatic keratotomy .</brief_summary>
	<brief_title>Prospective Evaluation Effectiveness Femtosecond Laser-assisted Refractive Astigmatic Keratotomy .</brief_title>
	<detailed_description>The purpose prospective phase IV study act address predictability effectiveness astigmatic keratotomy eye femtolaser-assisted cataract surgery . Within prospective data collection laser-assisted Arcuate Incisions perform VICTUS™ Femtosecond Laser Platform . This study conduct Gemini eye clinic Zlin , Czech Republic Dr. Pavel Stodulka treat 50 eye . Patients recruit accord study inclusion/exclusion criterion .</detailed_description>
	<mesh_term>Astigmatism</mesh_term>
	<criteria>Clear corneal medium Patients must least 40 year age Mono bilateral Cataract treatment Keratometric astigmatism : ≥ 1.0 D ≤ 3 D Patients must read , understood Patient Information sign informed consent form Patients willing able return followup examination The maximum K value may exceed 60D , minimal value may small 37D Pachymetry data 78 mm zone available . Corneal disease pathology , corneal scar opacity , preclude transmission laser wavelength distort laser light Subjects poorly dilate pupil defect pupil prevents iris adequate retraction peripherally Lens/zonular instability , restrict , Marfan 's Syndrome , Pseudoexfoliation Syndrome , etc . Manifest Glaucoma Previous intraocular corneal surgery kind , include type surgery either refractive therapeutic purpose either eye Known sensitivity plan concomitant medication Patients regularly take medicine could influence result treatment respectively vision Patients disorder ocular muscle , nystagmus strabismus Patients keratoconus , keratectasia irregular cornea change Patients connective tissue weakness Patients blind one eye Subjects immune compromise carry diagnosis connective tissue disease , clinically significant atopic disease , insulin dependent diabetes mellitus , autoimmune disease , ocular herpes zoster simplex , endocrine disease , lupus , rheumatoid arthritis , collagenosis acute chronic illness increase risk subject confound outcome study . Abnormal examination result slit lamp , fundus examination IOL Master , age relate change acceptable Patients eye diseases decrease visual acuity macular degeneration , macular edema , proliferative diabetic Retinopathy Abnormal examination result Topography , age relate change acceptable Patients pregnant nursing Patients concentration disorder , epilepsy complicating diseases Patients participate another clinical study 30 day</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Astigmatism , arcuate incision , astigmatic keratotomy</keyword>
</DOC>